|
Sanofi-aventis at a glance
Corporate management
- To print this page, please use the File menu or press simultaneously ctrl + p keys.
- Send this page
|
Chris Viehbacher
|
Executive Committee
The Committee meets twice a month. It is chaired by the Chief Executive Officer, Chris Viehbacher, and has the following permanent members.
|
Jérôme Contamine
|
|
Hanspeter Spek
|
|
Marc Cluzel
|
|
Laurence Debroux
|
|
Gilles Lhernould
|
|
Karen Linehan
|
|
Philippe Luscan
|
Management Committee
Chaired by the Chief Executive Officer, Chris Viehbacher, it is composed of the Executive Committee’s members as well as the following members:
|
Pierre Chancel Senior Vice President Global Marketing & Access
|
|
Olivier Charmeil Senior Vice President Pharmaceutical Operations Asia/Pacific and Japan
|
|
Philippe Fauchet Senior Vice President Business Development
|
|
Belén Garijo Senior Vice President Pharmaceutical Operations Europe and Canada (excluding France)
|
|
Gregory Irace Senior Vice President Pharmaceutical Operations United States
|
|
Marie-Hélène Laimay Senior Vice President Audit and Internal Control Assessment
|
|
Christian Lajoux Senior Vice President Pharmaceutical Operations France
|
|
Jean-Pierre Lehner Senior Vice President, Chief Medical Officer
|
|
Antoine Ortoli Senior Vice President Pharmaceutical Operations Intercontinental
|
|
Philippe Peyre Senior Vice President Corporate Affairs
|
|
Wayne Pisano Senior Vice President Vaccines
|
|
Jean-Philippe Santoni Senior Vice President Industrial Development and Innovation
|
|
Laure Thibaud Senior Vice President Communications
|
Further information:
|